Program

Dr. Jiann-Shing Jeng is professor and director at Department of Neurology, College of Medicine, National Taiwan University, and National Taiwan University Hospital. Besides, he is President of both Taiwan Neurological Society and Taiwan Neurocritical Care Society. He had ever been the President of Taiwan Stroke Society, and chief editor of Formosan Journal of Stroke. He is honorary director of Taiwan Stroke Society, editor of the Journal of the Formosan Medical Association. His research interests focus on cerebrovascular diseases, neurocritical care, neurosonology and neuroepidemiology. He is the principal investigator of Taiwan Registry of Endovascular Thrombectomy for Acute lschemic Stroke (TREAT-AIS), and Taiwan Post-Stroke Disability Study (T-PODS). Dr. Jeng has published more than 300 peer-reviewed papers published in international outstanding journals, including NEJM, Lancet Neurology, BMJ, Circulation, Annals of Neurology, Brain, Neurology, JNNP, Stroke, Journal of Stroke, Stroke & Vascular Neurology, International Journal of Stroke, Stroke: Vascular and Interventional Neurology, European Journal of Neurology, European Stroke Journal, Scientific Reports, Journal of the Neurological Sciences, etc

Dr. Rou-Shayn Chen devoted himself to the specialty of movement disorders for more than 25 years and chaired the Division of Movement Disorders, Department of Neurology, Chang Gung Memorial Hospital for more than 10 years from 2004 to 2014. He was the President of the Taiwan Movement Disorders Society (TMDS) from 2011 to 2013 and the Taiwan Neurological Society from 2019 to 2021. Since November 2025, he is the President of Asia-Oceania Chapter of International Federation of Clinical Neurophysiology (AO Chapter -IFCN)
He is also the current principal executive director of the Taiwan Neurophysiological Society and Taiwan Movement Disorder Society. His major clinical works focus on diagnosis and pharmacological intervention of Parkinson’s disease and dystonia. He was one of the pioneers to use botulinum toxin in treating dystonic patients especially with focal hand dystonia. During the past decade, He also built up one registration system for clinical follow up in detail of Parkinson’s disease in Taiwan.
Dr. Chen's research is focused on the neurophysiology of cortical plasticity, repetitive transcranial magnetic stimulation with the theta burst paradigm, and transcranial low-intensity ultrasound stimulation. He has also delved into the complex issues of non-motor symptoms and gait problems in patients with Parkinson's disease, contributing to our understanding of the condition. Moreover, Dr. Chen paid special attention to the gait disturbance with focus on the freezing of gait in neurodegenerative disorders. In recent 5 years, Dr. Chen proposed the research program of transcranial low-intensity focused ultrasound in the field of neuromodulation

Dr. Jui-Cheng Chen is the director of neurology from the CMUH and the current president of Taiwan Society of Clinical Neurophysiology. He has his PhD from Queen square and trained "focused ultrasound" at Stanford University. Dr. Chen is committed to innovative treatments for movement disorders. His current main topics include botulinum toxin treatment of dystonia, transcranial magnetic stimulation treatment of stroke, stem cell therapy, and Parkinson's treatment with the Shenbo Knife. Dr. Chen is a director of the Society of Clinical Neurophysiology and has been engaged in education on transcranial magnetic stimulation and electrical stimulation for many years. Hope that research can make medicine more advanced and benefit patients